Literature DB >> 6286505

Effect of Bordetella pertussis on alpha 1 and beta-adrenergic and cholinergic muscarinic receptors in guinea pig lung membranes.

H Mita, Y Yui, M Suzuki, H Yasueda, T Shida.   

Abstract

After intraperitoneal injection of Bordetella pertussis vaccine to guinea pigs, the alpha 1- and beta-adrenergic and cholinergic muscarinic receptors of the whole lung were measured by binding assays with the radioisotope-labeled antagonists, 3H-prazosin, 1-(3)H-dihydroalprenolol and 1-(3)H-quinuclidinyl benzilate, respectively. Injection of guinea pigs with pertussis vaccine resulted in an increase in the maximum binding (Bmax) of 3H-prazosin, while there was about a 30% reduction in 1-(3)H-dihydroalprenolol binding to beta-adrenergic receptors. No difference was observed in the dissociation constant (KD) for binding of each ligand to alpha 1- and beta-adrenergic receptors. 1-(3)H-quinuclidinyl benzilate binding indicated that the Bmax and KD for cholinergic muscarinic receptor in pertussis-sensitized guinea pigs were not significantly different from those normal control animals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286505     DOI: 10.1159/000233166

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

Review 1.  Adrenoceptors and the lung: their role in health and disease.

Authors:  D Reinhardt
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

2.  Beta adrenoceptor binding and induced relaxation in airway smooth muscle from patients with chronic airflow obstruction.

Authors:  C J van Koppen; J F de Miranda; A J Beld; C L van Herwaarden; J W Lammers; C A van Ginneken
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

3.  Characterization of the muscarinic receptor in human tracheal smooth muscle.

Authors:  C J van Koppen; J F Rodrigues de Miranda; A J Beld; M W Hermanussen; J W Lammers; C A van Ginneken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.